Track Conduit Pharmaceuticals Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Conduit Pharmaceuticals Inc. Common Stock CDT · Stock Open Conduit Pharmaceuticals Inc. Common Stock in new tab

0.4004 USD
EPS
1816250.00
P/B
0.00
ROE
-69.68
Beta
1.69
Loading chart...
Key Metrics
Earnings dateNov. 12, 2026
EPS1816250.00
Book Value4084.02
Price to Book0.00
Debt/Equity1.15
% Insiders17.517%

DCF valuation

Model fair value for Conduit Pharmaceuticals Inc. Common Stock (CDT)
Result
Sign in to run the valuation for CDT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Conduit Pharmaceuticals Inc. Common Stock Logo Conduit Pharmaceuticals Inc. Common Stock Analysis (CDT)

United States Health Care Official Website Stock

Is Conduit Pharmaceuticals Inc. Common Stock a good investment? Conduit Pharmaceuticals Inc. Common Stock (CDT) is currently trading at 0.4004 USD.

Earnings Schedule: Conduit Pharmaceuticals Inc. Common Stock is expected to release its next earnings report on Nov. 12, 2026.

Investor FAQ

Does Conduit Pharmaceuticals Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Conduit Pharmaceuticals Inc. Common Stock?

Conduit Pharmaceuticals Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of 1816250.00.

Company Profile

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Exchange Ticker
NMS (United States) CDT
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Jan. 27, 2025 1:100
May 20, 2025 1:15
Oct. 13, 2025 1:8
March 27, 2026 1:25
July 20, 2026 1:10
Sept. 29, 2026 1:25
Nov. 6, 2026 1:20
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion